Delivery Order SPE2DB24D6041-SPE2DB25FKCMH
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,369.59 to AmerisourceBergen Drug Corp for the supply of Doxycycline Hyclate 100 mg tablets (500 count) under a firm fixed price contract type. The award, issued on August 22, 2025, with an ultimate completion date of August 25, 2025, represents a non-competitive set-aside delivery order fulfilled from the vendor's existing contract vehicle. Performance will be completed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in a quantity of 1,000 units, valued at $1,565.14. This contract utilizes firm fixed pricing and carries an ultimate completion date of July 11, 2025. The award represents a non-set-aside, competitively awarded delivery order with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,126.63 to AmerisourceBergen Drug Corp for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 1,000 units. This contract, issued on May 19, 2025, with an ultimate completion date of May 20, 2025, represents a firm fixed-price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award falls under the company's...
- The Defense Logistics Agency awarded a $1,199.28 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 1,000 units. This is a firm fixed-price, non-set-aside contract with a completion date of September 11, 2025, and performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's significant role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 1,000 units, with a contract value of $1,085.95. This competitively awarded, non-set-aside delivery order carries a firm fixed price and an ultimate completion date of May 7, 2025. The contract is performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Doxycycline Hyclate 100 mg tablets (1,000 count) on July 15, 2025, with a ceiling value of $1,299.23 and ultimate completion by July 16, 2025. This firm fixed-price delivery order represents a small-value pharmaceutical transaction within the federal medical supply chain. The contract is not designated as a set-aside procurement and will be performed at AmerisourceBergen's facility in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 6, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 1,000 units, valued at $2,151.96. This is a firm fixed price delivery order with an ultimate completion date of June 9, 2025, and represents a non-competitive set-aside contract. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 23, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 1,000 units. This competitively awarded, non-set-aside contract carries a ceiling value of $1,575.24 with a firm fixed price structure and an ultimate completion date of June 24, 2025. The contractor will perform at its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 500 units, with a contract ceiling value of $2,077.68. This is a firm fixed-price delivery order with an ultimate completion date of July 23, 2025, and represents a non-set-aside competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $1,000.28 to AmerisourceBergen Drug Corp for Doxycycline Hyclate 50 mg capsules (500-count supply) on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, non-set-aside contract employs firm fixed-price pricing and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DB24D6041Indefinite Delivery Contract
- SPE2DB24D6041-SPE2DB25FKCMHDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,736.07 to AmerisourceBergen Drug Corp for the procurement of Doxycycline Hyclate 100 mg tablets (1,000 count) on August 27, 2025, with an ultimate completion date of August 28, 2025. This delivery order was issued under a firm fixed price structure with no set-aside designation, awarded through open competition. The place of performance is listed as the vendor's corporate office location in Conshohocken, Pennsylvania. As a delivery order, this contract represents a discrete purchase against AmerisourceBergen's larger indefinite delivery contract with DLA. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order draws from the company's comprehensive Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), which enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract portfolio includes specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 8/27/25 |